Saturday, October 17, 2026 · Edition updated 6:00 AM ETSAT, OCT 17 · 6 AM ET editionNext edition in Next --:--:--

A trial testing a gut supplement in older adults with mild memory problems

Recruiting · EARLY PHASE 1 · University of South Florida

What this means

This study will give some people capsules and others placebo capsules, then compare gut health, inflammation, and thinking skills. It has not reported results yet, so it does not show whether the capsules help.

Plain-English summary written by an AI model from the registry listing.

Status
Recruiting
Who can join
Ages 60 and over
Where
1 site, including Florida

Contacts and how to join ↗

The science

Registered title
LpD3.5 Intervention Study in Older Adults- LISA-I Trial
Phase
EARLY PHASE 1
Study type
interventional
Conditions
Mild Cognitive Impairment (MCI), Cognition, Brain Aging, Microbiome Dysbiosis, Leaky Gut Syndrome, Gut Inflammation, Inflammaging
What is tested
LpD3.5, Placebo
Sponsor
University of South Florida
Ages
60 Years to no maximum
Dates
First posted Aug 31, 2026 · updated Aug 31, 2026

Registry summary

This randomized placebo-controlled clinical study, called the LpD3.5 Intervention Study in Older Adults (LISA), aims to evaluate whether a heat-inactivated postbiotic of human origin (LpD3.5) can serve as a non-pharmacological intervention to reduce gut permeability and inflammation in older adults with mild cognitive impairment (MCI). The study will assess the effects of LpD3.5 supplementation on markers associated with gut health, inflammation, microbiome composition, and cognitive function.

Participants aged 60 years or older with clinically diagnosed MCI will receive either LpD3.5 capsules or placebo capsules for 60 days, followed by a 30-day follow-up period. Biological samples and clinical assessments will be collected to evaluate changes in gut permeability, inflammatory markers, microbiome characteristics, and cognitive outcomes. The findings from this study may provide insight into the potential role of postbiotics as a dietary intervention to improve gut health and related outcomes in older adults with MCI.

Sites (1)

  • Department of Neurosurgery and Brain and Spine and Faculty of USF Center for Microbiome Re-search, Microbiomes Institute, Tampa, Florida, United States

More aging trials in these states

Florida

Report a problem